Advance Search
LIN Lingdan, XU Shida, XING Haiyan. Value of serum interleukin-17 in predicting slow flow or no reflow after percutaneous coronary intervention in patients with ST-elevation myocardial infarction[J]. Journal of Clinical Medicine in Practice, 2021, 25(11): 93-95, 100. DOI: 10.7619/jcmp.20210482
Citation: LIN Lingdan, XU Shida, XING Haiyan. Value of serum interleukin-17 in predicting slow flow or no reflow after percutaneous coronary intervention in patients with ST-elevation myocardial infarction[J]. Journal of Clinical Medicine in Practice, 2021, 25(11): 93-95, 100. DOI: 10.7619/jcmp.20210482
shu

Value of serum interleukin-17 in predicting slow flow or no reflow after percutaneous coronary intervention in patients with ST-elevation myocardial infarction

  • Department of Cardiology, Dezhou City People's Hospital, Dezhou, Shandong, 253000

More Information
  • Received Date: January 25, 2021
  • Available Online: June 14, 2021
  • Published Date: June 14, 2021
    Graphical Abstract
    • Abstract
  •   Objective  To explore the value of serum interleukin-17 (IL-17) level in predicting slow flow or no reflow after percutaneous coronary intervention (PCI) in patients with ST-elevation myocardial infarction (STEMI).
      Methods  Totally 120 STEMI patients with emergency PCI were divided into slow flow and no reflow group (n=27) and normal flow group (n=93) according to coronary blood flow status after PCI. The serum IL-17 level and clinical data were compared between the two groups. The factors influencing slow flow or no reflow were analyzed by the binary Logistic regression model. The predictive indexes for slow flow or no reflow were analyzed by receiver operating characteristic (ROC) curve.
      Results  The levels of IL-17, creatine kinase isoenzyme-MB (CK-MB), cardiac troponin I (cTnI) and C-reactive protein (CRP) in the slow flow and no reflow group were significantly higher than those in the normal flow group (P < 0.05).
      Conclusion  IL-17 was the influencing factor of slow flow or no reflow, the increase of serum IL-17 level is related to the occurrence of slow flow or no reflow after PCI, and the detection of IL-17 has a predictive value for slow flow or no reflow after PCI.
    • FullText(HTML)
    • References (16)
  • [1]
    DALLARA G, TESTA L, TUMSCITZ C, et al. No-Reflow Complicating Chronic Total Occlusion Coronary Revascularization[J]. J Invasive Cardiol, 2020, 32(2): 58-63. https://pubmed.ncbi.nlm.nih.gov/32005785/
    [2]
    BUONO A, GORI T. No-reflow phenomenon in acute myocardial infarction: Relieve pressure from the procedure and focus attention to the patient[J]. Int J Cardiol Heart Vasc, 2019, 30(24): 100417. http://www.sciencedirect.com/science/article/pii/S2352906719301824
    [3]
    DEL TURCO S, BASTA G, DE CATERINA A R, et al. Different inflammatory profile in young and elderly STEMI patients undergoing primary percutaneous coronary intervention (PPCI): Its influence on no-reflow and mortality[J]. Int J Cardiol, 2019, 1(290): 34-39. https://www.sciencedirect.com/science/article/pii/S0167527319311969
    [4]
    PEI W N, HU H J, LIU F, et al. C-reactive protein aggravates myocardial ischemia/reperfusion injury through activation of extracellular-signal-regulated kinase 1/2[J]. J Geriatr Cardiol, 2018, 15(7): 492-503. http://www.jgc301.com/ch/reader/view_abstract.aspx?file_no=20180526001&flag=1&type=online
    [5]
    袁杰, 刘巧丽, 王广友, 等. IL-17和ICAM-1在大鼠急性心肌缺血再灌注后无复流现象中的表达[J]. 哈尔滨医科大学学报, 2011, 45(5): 401-404, 408. doi: 10.3969/j.issn.1000-1905.2011.05.002
    [6]
    中华医学会心血管病学分会, 中华心血管病杂志编辑委员会. 急性ST段抬高型心肌梗死诊断和治疗指南[J]. 中华心血管病杂志, 2015, 43(5): 380-393. doi: 10.3760/cma.j.issn.0253-3758.2015.05.003
    [7]
    杨汆, 胡文志, 王迪斌, 等. STEMI患者PCI术前预注射尼可地尔对无复流的预防作用[J]. 临床心血管病杂志, 2019, 35(4): 335-339. https://www.cnki.com.cn/Article/CJFDTOTAL-LCXB201904011.htm
    [8]
    孙小强, 李姮, 何峰. 冠脉内注射硝普钠对老年STEMI患者直接PCI预防无复流现象的疗效评价[J]. 天津医药, 2019, 47(1): 47-50. https://www.cnki.com.cn/Article/CJFDTOTAL-TJYZ201901013.htm
    [9]
    SU Q, LV X, SUN Y, et al. Role of TLR4/MyD88/NF-κB signaling pathway in coronary microembolization-induced myocardial injury prevented and treated with nicorandil[J]. Biomed Pharmacother, 2018, 106: 776-784. doi: 10.1016/j.biopha.2018.07.014
    [10]
    SU Q, LV X, YE Z, et al. The mechanism of miR-142-3p in coronary microembolization-induced myocardiac injury via regulating target gene IRAK-1[J]. Cell Death Dis, 2019, 10(2): 61. doi: 10.1038/s41419-019-1341-7
    [11]
    侯娜, 张雪娥, 张瑞娟. 冠状动脉斑块患者血清白介素17水平的变化及其临床意义[J]. 山西医科大学学报, 2019, 50(4): 394-399. https://www.cnki.com.cn/Article/CJFDTOTAL-SXYX201904003.htm
    [12]
    盘德辉, 梁健球. 冠心病患者血清IL-17A水平变化及与冠状动脉狭窄程度和超敏C反应蛋白的关系[J]. 广东医学, 2017, 38(13): 2027-2030. doi: 10.3969/j.issn.1001-9448.2017.13.023
    [13]
    ZHAO Y, YANG J, JI Y, et al. Usefulness of fibrinogen-to-albumin ratio to predict no-reflow and short-term prognosis in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention[J]. Heart Vessels, 2019, 34(10): 1600-1607. doi: 10.1007/s00380-019-01399-w
    [14]
    ASHRAF T, KHAN M N, AFAQUE S M, et al. Clinical and procedural predictors and short-term survival of the patients with no reflow phenomenon after primary percutaneous coronary intervention[J]. Int J Cardiol, 2019, 1(294): 27-31. http://www.sciencedirect.com/science/article/pii/S0167527319326919
    [15]
    张卫君, 胡铂. 血浆D-二聚体水平对急性ST段抬高型心肌梗死经皮冠状动脉介入治疗术中无复流的预测价值[J]. 上海医学, 2019, 42(2): 65-69. https://www.cnki.com.cn/Article/CJFDTOTAL-SHYX201902001.htm
    [16]
    曹梦珠, 乔增勇. 急性ST段抬高型心肌梗死急诊冠状动脉支架置入后慢血流或无复流现象的影响因素[J]. 中华老年心脑血管病杂志, 2020, 22(3): 257-260. doi: 10.3969/j.issn.1009-0126.2020.03.009
    • Related Articles

  • Related Articles

    [1]REN Lili, WANG Wenjuan, Gulinazaer·AIBIBULA, Gulixian·MAHEMUTI. Expression levels and significance of serum T lymphocyte subsets and cytokines in patients with different inflammatory phenotypes of bronchial asthma[J]. Journal of Clinical Medicine in Practice, 2022, 26(22): 33-37. DOI: 10.7619/jcmp.20221392
    [2]LONG Qiaobo, CAI Xiang, ZHU Xiaoqiang. Efficacy of Xiyanping inhalation combined with acyclovir in treatment of children with herpangina and its influence on inflammatory factors[J]. Journal of Clinical Medicine in Practice, 2017, (3): 99-101. DOI: 10.7619/jcmp.201703030
    [3]ZHANG Bingbing. Study on correlation between myocardial enzyme and cytokines of newborns with aspiration pneumonia[J]. Journal of Clinical Medicine in Practice, 2017, (1): 100-102. DOI: 10.7619/jcmp.201701030
    [4]ZHOU Weizhong. Efficacy of adjuvant therapy of tanreqing injection in treatment of children with mycoplasma pneumoniae pneumonia and its influence on serum inflammatory cytokine levels[J]. Journal of Clinical Medicine in Practice, 2015, (11): 182-184. DOI: 10.7619/jcmp.201511068
    [5]LIU Guangming. Effect of continuous blood purification combined with low molecular weight heparin on inflammatory cytokines clear and renal protection in patients with severe sepsis[J]. Journal of Clinical Medicine in Practice, 2015, (3): 44-46. DOI: 10.7619/jcmp.201503012
    [6]HUANG Yanjun, ZHENG Guo, CHEN Jing. Expression and clinical significance of inflammatory cytokines and C-reactive protein in peripheral blood of children with epilepsy[J]. Journal of Clinical Medicine in Practice, 2014, (24): 40-42. DOI: 10.7619/jcmp.201424012
    [7]HU Dejian, ZHANG Xiangmei. Influence of different dose of sensitinogen on serum specific antibody and inflammatory cytokines in allergic asthma model in mice[J]. Journal of Clinical Medicine in Practice, 2014, (21): 8-11. DOI: 10.7619/jcmp.201421003
    [8]CHEN Dali, XU Yongmei, PENG Lan, YANG Yongqing, CHAI Liqiang. Changes of plasma NT-proBNP and inflammatory cytokines levels before and after treatment for preeclampsia[J]. Journal of Clinical Medicine in Practice, 2014, (17): 73-75,79. DOI: 10.7619/jcmp.201417021
    [9]CHENG Jun. Influence of intravenous inhalation anesthesia and total intravenous anesthesia on inflammatory cytokines of patients with breast cancer[J]. Journal of Clinical Medicine in Practice, 2014, (5): 51-53. DOI: 10.7619/jcmp.201405016
    [10]LI Hong, DAI Qiang, QIAN Liya, QIAN Kewei. Relationship between impaired glucose tolerance and serum adiponectin, inflammatory cytokines in adolescents with simple obesity[J]. Journal of Clinical Medicine in Practice, 2013, (17): 20-22,26. DOI: 10.7619/jcmp.201317006

Catalog

    Get Citation
    PDF
    XML
    Article views (361) PDF downloads (12) Cited by()
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    © 2020 《实用临床医药杂志》编辑部

    Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807

    苏公网安备 32100302010246号

    Supported by: Beijing Renhe Information Technology Co., Ltd.   Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return